Printer Friendly Version
Printer Friendly Version
Printer Friendly Version
L.4.01.400
The purpose of this policy is to reduce non-medically indicated (elective) deliveries prior to 39 weeks.
Induction of labor is the artificial start of the birth process through medical interventions or other methods. Elective induction is defined as induction of labor when there is no clear medical benefit to the mother or child for delivery at that point in time compared with continuation of pregnancy. An elective cesarean section is defined as a scheduled initial or repeat cesarean delivery with no medical indication before 39 weeks. Every week of gestation matters for the health of newborns. On average, a pregnancy with a single fetus lasts 40 weeks from the first day of the last menstrual period. The last few weeks of pregnancy within these 40 weeks allow a baby’s brain and lungs to fully mature. Babies born between 39 weeks 0 days and 40 weeks 6 days gestation have the best health outcomes, compared with babies born before or after this period. This distinct time period is now referred to as “Full Term.” The following represent the four definitions of ‘term’ deliveries:
Early Term: 37 weeks 0 days to 38 weeks 6 days
Full Term: 39 weeks 0 days to 40 weeks 6 days
Late Term: 41 weeks 0 days to 41 weeks 6 days
Postterm: Between 42 weeks 0 days and beyond
Efforts to improve the quality and safety of perinatal care have received increased focus during recent years. Research has shown that elective early-term delivery without medical or obstetrical indication is linked to neonatal morbidities and has no benefit to the mother or infant. The American College of Obstetricians and Gynecologists (ACOG) publications have consistently advised against non-medically indicated elective deliveries prior to 39 weeks gestation. Despite ACOG guidelines, elective early-term labor inductions and cesarean sections are common and increasing in the United States and are creating concern about trends in current obstetric practice. Educating healthcare providers about morbidities associated with practice trends fosters evidence-based decision-making and leads to improved practices that reduce harm.
ACOG and the Society for Maternal-Fetal Medicine have long discouraged nonindicated delivery before 39 weeks of gestation. The reason for this longstanding principle is that the neonatal risks of late-preterm (34 0/7–36 6/7 weeks of gestation) and early-term (37 0/7–38 6/7 weeks of gestation) births are well established. However, there are a number of maternal, fetal, and placental complications in which either a late-preterm or early-term delivery is warranted. The timing of delivery in such cases must balance the maternal and newborn risks of late-preterm and early-term delivery with the risks of further continuation of pregnancy.
There are several important principles to consider in the timing of delivery. First, the decision making regarding timing of delivery is complex and must take into account relative maternal and newborn risks, practice environment, and patient preferences. Second, late-preterm or early-term deliveries may be warranted for either maternal or newborn benefit or both. In some cases, health care providers will need to weigh competing risks and benefits for mother and newborn; therefore, decisions regarding timing of delivery must be individualized. Additionally, recommendations such as these are dependent on accurate determination of gestational age.
Further, ACOG has stated that a mature fetal lung maturity profile is not an indication for delivery in the absence of other clinical indications. Yet, the rate of non-medically indicated early-term (37 0/7–38 6/7 weeks of gestation) deliveries continues to increase in the United States. In contrast, the late-preterm (34 0/7–36 6/7 weeks of gestation) birth rate, which increased 25% from 1990 to 2006, has leveled off and started a slow decrease from 9.1% in 2006 to 8.8% in 2008. There are medical indications in pregnancy for which there is evidence or expert opinion to support expedient delivery in the early-term period versus expectant management. In contrast, suspected macrosomia and documented pulmonary maturity with no other indication are all examples of conditions that are not indications for an early-term delivery.
Induction of labor or cesarean section prior to 39 weeks gestation may be considered medically necessary for the following medical and obstetric indications:
Cardiovascular diseases (congenital and other)
Chorioamnionitis
Chronic hypertension
Fetal demise
Fetal demise in prior pregnancy
Fetal malformation
Gestational hypertension
Gestational diabetes with Insulin
HIV infection
Intrauterine Growth Restriction (IUGR)
Isoimmunization
Liver diseases (including cholestasis of pregnancy)
Multiple gestation
Non-reassuring fetal status
Oligohydramnios
Placental abruption
Placenta previa
Polyhydramnios
Preeclampsia
Preexisting diabetes (Type I or Type II)
Premature rupture of membranes (PROM)
Classical or vertical uterine incision from prior cesarean delivery
Prior myomectomy
Pulmonary disease
Renal disease
Thrombophilia/Maternal coagulation defects in pregnancy
Antiphospholipid Syndrome
Other indication – Must be approved by the Obstetrics and Gynecology department chair or designee with the reason clearly documented in the medical record
Induction of labor or cesarean section prior to 39 weeks gestation is considered not medically necessary for all other indications, including but not limited to:
Any medical or obstetric indication not listed above, including suspected macrosomia and documented pulmonary maturity with no other indication
Convenience of the patient
Convenience of the patient's family
Convenience of the physician
Partner soon leaving town (including military deployment)
Maternal exhaustion or discomfort
The mother has rapid deliveries
Mother lives a long distance from the hospital
Adoption
None
The coverage guidelines outlined in the Medical Policy Manual should not be used in lieu of the Member's specific benefit plan language.
Gestational age must be confirmed and documented in the medical record using one of the ACOG criteria:
Ultrasound measurement at less than 20 weeks of gestation supports a gestational age of 39 weeks or greater.
Fetal heart tones have been documented as present for 30 weeks by Doppler ultrasonography.
It has been 36 weeks since a positive serum or urine human chorionic gonadotropin pregnancy test.
39 weeks or more have elapsed since the first day of the last menstrual period in women with a regular menstrual cycle.
If the patient does not meet ACOG’s criteria for confirmation of gestational age, an amniocentesis to confirm fetal lung maturity after 39 weeks or allowing the patient to go into labor should be considered. Amniocentesis and documentation of fetal lung maturity is not an indication for delivery prior to 39 weeks.
Investigative service is defined as the use of any treatment procedure, facility, equipment, drug, device, or supply not yet recognized by certifying boards and/or approving or licensing agencies or published peer review criteria as standard, effective medical practice for the treatment of the condition being treated and as such therefore is not considered medically necessary.
11/21/2014: New policy added. Approved by Medical Policy Advisory Committee. Effective 01/01/2015.
01/01/2015: Code Reference section updated to add ICD-9 diagnosis codes 644.20 and 644.21.
01/06/2015: Code Reference section updated to add ICD-9 diagnosis codes 649.81 and 649.82.
08/31/2015: Code Reference section updated for ICD-10. Extended ICD-9 diagnosis code 519 to 519.2. Extended diagnosis code 789.5 to the fifth digit as 789.51 and 789.59. Extended diagnosis code 866 to the fifth digit as 866.00 – 866.13. Corrected transposed code 647.54 to 674.54.
06/09/2016: Policy number L.4.01.400 added.
09/30/2016: Code Reference section updated to add the following new ICD-10 diagnosis codes: I16.0, I16.1, I16.9, J98.51, J98.59, N13.0, O34.212, and O44.20 - O44.53. Revised code descriptions for ICD-10 diagnosis codes T82.817A - T82.817s, T82.818A - T82.818S, O44.0 - O44.03, O44.10 - O44.13, and P01.6.
09/29/2017: Code Reference section updated to add new ICD-10 diagnosis codes I50.810, I50.811, I50.812, I50.813, I50.814, I50.82, I50.83, I50.84, I50.89, P29.38, and P78.84, effective 10/01/2017. Revised code description for ICD-10 diagnosis code J15.6. Removed deleted ICD-10 diagnosis codes J98.5 and O34.21 and ICD-9 diagnosis codes 654.20 - 654.23.
09/27/2018: Code Reference section updated to add new ICD-10 diagnosis code K83.01. Revised description for ICD-10 procedure codes 10D00Z0 and 10D00Z1. Effective 10/01/2018.
09/23/2019: Code Reference section updated to add new ICD-10 diagnosis codes I26.93 and I26.94, effective 10/01/2019. Removed deleted ICD-10 diagnosis codes P29.3 and Z36. Removed ICD-9 diagnosis code V28.5.
09/25/2020: Code Reference section updated to add new ICD-10 diagnosis codes J82.81, J82.82, J82.83, J82.89, J84.170, J84.178, K74.00, K74.01, K74.02, N18.30, N18.31, N18.32, O34.218, and O34.22, effective 10/01/2020. Revised code descriptions for ICD-10 diagnosis codes D57.411 and D57.412, effective 10/01/2020. Removed deleted ICD-10 diagnosis code K83.0.
12/15/2020: Code Reference section updated to add new ICD-10 diagnosis code J12.82, effective 01/01/2021.
12/21/2021: Code Reference section updated to revise code description for ICD-10 diagnosis code M35.02 and to remove deleted ICD-10 diagnosis codes J82 and K74.0.
09/20/2022: Code Reference section updated to add new ICD-10 diagnosis codes D68.00, D68.01, D68.020, D68.021, D68.022, D68.023, D68.029, D68.03, D68.04, D68.09, D75.821, D75.822, D75.828, D75.829, I20.2, I25.112, I25.702, I25.712, I25.722, I25.732, I25.752, I25.762, I25.792, I34.81, I34.89, K76.82, N80.00, N85.A, O35.00X0, O35.00X1, O35.00X2, O35.00X3, O35.00X4, O35.00X5, O35.00X9, O35.01X0, O35.01X1, O35.01X2, O35.01X3, O35.01X4, O35.01X5, O35.01X9, O35.02X0, O35.02X1, O35.02X2, O35.02X3, O35.02X4, O35.02X5, O35.02X9, O35.03X0, O35.03X1, O35.03X2, O35.03X3, O35.03X4, O35.03X5, O35.03X9, O35.04X0, O35.04X1, O35.04X2, O35.04X3, O35.04X4, O35.04X5, O35.04X9, O35.05X0, O35.05X1, O35.05X2, O35.05X3, O35.05X4, O35.05X5, O35.05X9, O35.06X0, O35.06X1, O35.06X2, O35.06X3, O35.06X4, O35.06X5, O35.06X9, O35.07X0, O35.07X1, O35.07X2, O35.07X3, O35.07X4, O35.07X5, O35.07X9, O35.08X0, O35.08X1, O35.08X2, O35.08X3, O35.08X4, O35.08X5, O35.08X9, O35.09X0, O35.09X1, O35.09X2, O35.09X3, O35.09X4, O35.09X5, O35.09X9, O35.10X0, O35.10X1, O35.10X2, O35.10X3, O35.10X4, O35.10X5, O35.10X9, O35.11X0, O35.11X1, O35.11X2, O35.11X3, O35.11X4, O35.11X5, O35.11X9, O35.12X0, O35.12X1, O35.12X2, O35.12X3, O35.12X4, O35.12X5, O35.12X9, O35.13X0, O35.13X1, O35.13X2, O35.13X3, O35.13X4, O35.13X5, O35.13X9, O35.14X0, O35.14X1, O35.14X2, O35.14X3, O35.14X4, O35.14X5, O35.14X9, O35.15X0, O35.15X1, O35.15X2, O35.15X3, O35.15X4, O35.15X5, O35.15X9, O35.19X0, O35.19X1, O35.19X2, O35.19X3, O35.19X4, O35.19X5, O35.19X9, O35.AXX0, O35.AXX1, O35.AXX2, O35.AXX3, O35.AXX4, O35.AXX5, O35.AXX9, O35.BXX0, O35.BXX1, O35.BXX2, O35.BXX3, O35.BXX4, O35.BXX5, O35.BXX9, O35.CXX0, O35.CXX1, O35.CXX2, O35.CXX3, O35.CXX4, O35.CXX5, O35.CXX9, O35.DXX0, O35.DXX1, O35.DXX2, O35.DXX3, O35.DXX4, O35.DXX5, O35.DXX9, O35.EXX0, O35.EXX1, O35.EXX2, O35.EXX3, O35.EXX4, O35.EXX5, O35.EXX9, O35.FXX0, O35.FXX1, O35.FXX2, O35.FXX3, O35.FXX4, O35.FXX5, O35.FXX9, O35.GXX0, O35.GXX1, O35.GXX2, O35.GXX3, O35.GXX4, O35.GXX5, O35.GXX9, O35.HXX0, O35.HXX1, O35.HXX2, O35.HXX3, O35.HXX4, O35.HXX5, and O35.HXX9, effective 10/01/2022.
11/28/2022: Policy reviewed; no changes.
09/28/2023: Code Reference section updated to add new ICD-10 diagnosis codes E75.27, I1A.0, I24.81, I24.89, I20.81, I20.89, I25.85, I47.10, I47.11, I47.19, J15.61, J15.69, J44.81, J44.89, O26.643, O26.649, Q44.70, Q44.71, and Q44.79, effective 10/01/2023.
12/07/2023: Policy reviewed. Policy statements unchanged. Code Reference section updated to remove deleted ICD-10 diagnosis codes D68.0, N80.0, O35.0XX0, O35.0XX1, O35.0XX2, O35.0XX3, O35.0XX4, O35.0XX5, O35.0XX9, O35.1XX0, O35.1XX1, O35.1XX2, O35.1XX3, O35.1XX4, O35.1XX5, and O35.1XX9.
12/16/2024: Policy reviewed. Policy statements unchanged. Code Reference section updated to remove deleted ICD-10 diagnosis codes I20.8 and J15.6.
OB/GYN Physician Advisory Committee
Medically Indicated Late-Preterm and Early-Term Deliveries. The American College of Obstetricians and Gynecologists Committee on Obstetric Practice the Society for Maternal–Fetal Medicine. Number 560, April 2013
Nonmedically Indicated Early-Term Deliveries. The American College of Obstetricians and Gynecologists Committee on Obstetric Practice the Society for Maternal–Fetal Medicine. Number 561, April 2013
Ob-Gyns Redefine Meaning of "Term Pregnancy." The American College of Obstetricians and Gynecologists Committee on Obstetric Practice the Society for Maternal–Fetal Medicine. October 22, 2013
Elimination of Non-medically Indicated (Elective) Deliveries Before 39 Weeks Gestational Age. Collaborative project developed by: March of Dimes, California Maternal Quality Care Collaborative, and Maternal, Child and Adolescent Health Division; Center for Family Health California Department of Public Health
http://www.marchofdimes.com/professionals/less-than-39-weeks-toolkit.aspx
Specifications Manual for Joint Commission National Quality Measures (v2013A1), The Joint Commission, Table Number 11.07: Conditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestation
https://manual.jointcommission.org/releases/TJC2013A/
AppendixATJC.html# Table_Number_11_07_Conditions_Po
http://www.nnepqin.org/documentUpload/Guideline_for_Elective_Labor_Induction.pdf
https://www.acog.org/~/media/For%20Patients/faq154.pdf?dmc=1&ts=20140404T1728277022
This may not be a comprehensive list of procedure codes applicable to this policy.
The code(s) listed below are ONLY medically necessary if the procedure is performed according to the "Policy" section of this document.
Medically Necessary Codes
Code Number | Description | ||
CPT-4 | |||
01960 | Anesthesia for vaginal delivery only | ||
01961 | Anesthesia for cesarean delivery only | ||
01967 | Neuraxial labor analgesia/anesthesia for planned vaginal delivery (this includes any repeat subarachnoid needle placement and drug injection and/or any necessary replacement of an epidural catheter during labor) | ||
59400 | Routine obstetric care including antepartum care, vaginal delivery (with or without episiotomy, and/or forceps) and postpartum care | ||
59409 | Vaginal delivery only (with or without episiotomy and/or forceps); | ||
59410 | Vaginal delivery only (with or without episiotomy and/or forceps); including postpartum care | ||
59414 | Delivery of placenta (separate procedure) | ||
59510 | Routine obstetric care including antepartum care, cesarean delivery, and postpartum care | ||
59514 | Cesarean delivery only; | ||
59515 | Cesarean delivery only; including postpartum care | ||
59610 | Routine obstetric care including antepartum care, vaginal delivery (with or without episiotomy, and/or forceps) and postpartum care, after previous cesarean delivery | ||
59612 | Vaginal delivery only, after previous cesarean delivery (with or without episiotomy and/or forceps); | ||
59614 | Vaginal delivery only, after previous cesarean delivery (with or without episiotomy and/or forceps); including postpartum care | ||
59618 | Routine obstetric care including antepartum care, cesarean delivery, and postpartum care, following attempted vaginal delivery after previous cesarean delivery | ||
59620 | Cesarean delivery only, following attempted vaginal delivery after previous cesarean delivery; | ||
59622 | Cesarean delivery only, following attempted vaginal delivery after previous cesarean delivery; including postpartum care | ||
HCPCS | |||
J2590 | Injection, oxytocin, up to 10 units | ||
S0191 | Misoprostol, oral, 200 mcg | ||
ICD-9 Procedure | ICD-10 Procedure | ||
69.93 | Insertion of laminaria | 10A07ZW | Abortion of products of conception, laminaria, via natural or artificial opening |
72.0-72.9 | Forceps, vacuum, and breech delivery | 0W8NXZZ | Division of female perineum, external approach |
10A07Z6 | Abortion of products of conception, vacuum, via natural or artificial opening | ||
10D07Z3 | Extraction of products of conception, low forceps, via natural or artificial opening | ||
10D07Z4 | Extraction of products of conception, mid forceps, via natural or artificial opening | ||
10D07Z5 | Extraction of products of conception, high forceps, via natural or artificial opening | ||
10D07Z6 | Extraction of products of conception, vacuum, via natural or artificial opening | ||
10D07Z8 | Extraction of products of conception, other, via natural or artificial opening | ||
10S07ZZ | Reposition products of conception, via natural or artificial opening | ||
73.01-73.09 | Artificial rupture of membranes | 10900ZC | Drainage of amniotic fluid, therapeutic from products of conception, open approach |
10903ZC | Drainage of amniotic fluid, therapeutic from products of conception, percutaneous approach | ||
10904ZC | Drainage of amniotic fluid, therapeutic from products of conception, percutaneous endoscopic approach | ||
10907ZC | Drainage of amniotic fluid, therapeutic from products of conception, via natural or artificial opening | ||
10908ZC | Drainage of amniotic fluid, therapeutic from products of conception, via natural or artificial opening endoscopic | ||
73.1 | Other surgical induction of labor | 0U7C7ZZ | Dilation of cervix, via natural or artificial opening |
73.21-73.22 | Internal and combined version and extraction | 10S07ZZ | Reposition products of conception, via natural or artificial opening |
10D07Z7 | Extraction of products of conception, internal version, via natural or artificial opening | ||
73.3 | Failed forceps | 10J07ZZ | Inspection of products of conception, via natural or artificial opening |
73.4 | Medical induction of labor | 3E030VJ | Introduction of other hormone into peripheral vein, open approach |
3E033VJ | Introduction of other hormone into peripheral vein, percutaneous approach | ||
3E040VJ | Introduction of other hormone into central vein, open approach | ||
3E043VJ | Introduction of other hormone into central vein, percutaneous approach | ||
3E050VJ | Introduction of other hormone into peripheral artery, open approach | ||
3E053VJ | Introduction of other hormone into peripheral artery, percutaneous approach | ||
3E060VJ | Introduction of other hormone into central artery, open approach | ||
3E063VJ | Introduction of other Hormone into central artery, percutaneous approach | ||
3E0DXGC | Introduction of other therapeutic substance into mouth and pharynx, external approach | ||
73.51, 73.59 | Manually assisted delivery | 10E0XZZ | Delivery of products of conception, external approach |
74.0-74.99 | Cesarean section and removal of fetus | 10A00ZZ | Abortion of products of conception, open approach |
10A03ZZ | Abortion of products of conception, percutaneous approach | ||
10A04ZZ | Abortion of products of conception, percutaneous endoscopic approach | ||
10D00Z0 | Extraction of products of conception, high, open approach | ||
10D00Z1 | Extraction of products of conception, low, open approach | ||
10D00Z2 | Extraction of products of conception, extraperitoneal, open approach | ||
10T20ZZ | Resection of products of conception, ectopic, open approach | ||
10T23ZZ | Resection of products of conception, ectopic, percutaneous approach | ||
10T24ZZ | Resection of products of conception, ectopic, percutaneous endoscopic approach | ||
74.1 | Low cervical cesarean section | 10D00Z1 | Extraction of products of conception, low cervical, open approach |
74.4 | Cesarean section of other specified type | 10D00Z0 | Extraction of products of conception, classical, open approach |
96.49 | Other genitourinary instillation | 0WHR73Z | Insertion of infusion device into genitourinary tract, via natural or artificial opening |
0WHR7YZ | Insertion of other device into genitourinary tract, via natural or artificial opening | ||
10A07ZX | Abortion of products of conception, abortifacient, via natural or artificial opening | ||
3E1K78X | Irrigation of genitourinary tract using irrigating substance, via natural or artificial opening, diagnostic | ||
3E1K78Z | Irrigation of genitourinary tract using irrigating substance, via natural or artificial opening | ||
3E1K88X | Irrigation of genitourinary tract using irrigating substance, via natural or artificial opening endoscopic, diagnostic | ||
3E1K88Z | Irrigation of genitourinary tract using irrigating substance, via natural or artificial opening endoscopic | ||
ICD-9 Diagnosis | ICD-10 Diagnosis | ||
011.00-011.96 | Tuberculosis of lung, infiltrative | A15.0 | Tuberculosis of lung |
A15.5 | Tuberculosis of larynx, trachea and bronchus | ||
012.00-012.86 | Other respiratory tuberculosis | A15.4 | Tuberculosis of intrathoracic lymph nodes |
A15.5 | Tuberculosis of larynx, trachea and bronchus | ||
A15.6 | Tuberculous pleurisy | ||
A15.8 | Other respiratory tuberculosis | ||
A15.9 | Respiratory tuberculosis unspecified | ||
042 | Human immunodeficiency virus [HIV] disease | B20 | Human immunodeficiency virus [HIV] disease |
070.0-070.9 | Viral Hepatitis | B15.0 - B15.9 | Acute hepatitis A |
B16.0 - B16.9 | Acute hepatitis B | ||
B17.0 - B17.9 | Other acute viral hepatitis | ||
B18.0 - B18.9 | Chronic viral hepatitis | ||
B19.0 - B19.9 | Unspecified viral hepatitis | ||
079.53 | Human immunodeficiency virus, type 2 [HIV-2] | B97.35 | Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere |
016.00-016.06 | Tuberculosis of kidney | A18.11 | Tuberculosis of kidney and ureter |
135 | Sarcoidosis | D86.0 - D86.9 | Sarcoidosis |
155.0 | Malignant neoplasm of liver, primary | C22.0 | Liver cell carcinoma |
C22.2 | Hepatoblastoma | ||
C22.3 | Angiosarcoma of liver | ||
C22.4 | Other sarcomas of liver | ||
C22.7 | Other specified carcinomas of liver | ||
C22.8 | Malignant neoplasm of liver, primary, unspecified as to type | ||
155.1 | Malignant neoplasm of intrahepatic bile ducts | C22.1 | Intrahepatic bile duct carcinoma |
162.0-162.9 | Malignant neoplasm of trachea, bronchus, and lung | C33 | Malignant neoplasm of trachea |
C34.00 - C34.92 | Malignant neoplasm of bronchus and lung | ||
189.0 | Malignant neoplasm of kidney, except pelvis | C64.1 - C64.9 | Malignant neoplasm of kidney, except renal pelvis |
198.0 | Secondary neoplasm of kidney | C79.00 - C79.02 | Secondary malignant neoplasm of kidney and renal pelvis |
211.5 | Benign neoplasm of liver and biliary passages | D13.4 | Benign neoplasm of liver |
D13.5 | Benign neoplasm of extrahepatic bile ducts | ||
230.8 | Carcinoma in situ of liver and biliary system | D01.5 | Carcinoma in situ of liver, gallbladder and bile ducts |
231.2 | Carcinoma in situ of bronchus and lung | D02.20 - D02.22 | Carcinoma in situ of bronchus and lung |
250.00-250.93 | Diabetes mellitus (Type I and Type II) | E10.10 - E10.9 | Type 1 diabetes mellitus |
272.7 | Gaucher Disease | E75.21 | Fabry (-Anderson) disease |
E75.22 | Gaucher disease | ||
E75.240 - E75.249 | Niemann-Pick disease | ||
E75.27 | Pelizaeus-Merzbacher disease | ||
E75.3 | Sphingolipidosis, unspecified | ||
E77.0 - E77.9 | Disorders of glycoprotein metabolism | ||
275.01-275.09 | Disorders of iron metabolism | E83.10 - E83.19 | Disorders of iron metabolism |
275.1 | Wilson's Disease | E83.00 - E83.09 | Disorders of copper metabolism |
286.0-286.9 | Coagulation defects | D65 | Disseminated intravascular coagulation [defibrination syndrome] |
D66 | Hereditary factor VIII deficiency | ||
D67 | Hereditary factor IX deficiency | ||
D68.00, D68.01, D68.020, D68.021, D68.022, D68.023, D68.029, D68.03, D68.04, D68.09 | Von Willebrand's disease | ||
D68.1 | Hereditary factor XI deficiency | ||
D68.2 | Hereditary deficiency of other clotting factors | ||
D68.311 - D68.32 | Hemorrhagic disorder due to circulating anticoagulants | ||
D68.4 | Acquired coagulation factor deficiency | ||
D68.8 | Other specified coagulation defects | ||
D68.9 | Coagulation defect, unspecified | ||
287.0-287.9 | Purpura and other hemorrhagic conditions | D69.0 - D69.9 | Purpura and other hemorrhagic conditions |
289.0-289.9 | Other diseases of blood and blood-forming organs | D47.4 | Osteomyelofibrosis |
D57.02 | Hb-SS disease with splenic sequestration | ||
D57.212 | Sickle-cell/Hb-C disease with splenic sequestration | ||
D57.412 | Sickle-cell thalassemia, unspecified, with splenic sequestration | ||
D57.812 | Other sickle-cell disorders with splenic sequestration | ||
D68.51 - D68.59 | Primary thrombophilia | ||
D68.61 - D68.69 | Other thrombophilia | ||
D73.0 - D73.9 | Diseases of spleen | ||
D74.0 - D74.9 | Methemoglobinemia | ||
D75.0 - D75.9 | Other and unspecified diseases of blood and blood-forming organs | ||
D77 | Other disorders of blood and blood-forming organs in diseases classified elsewhere | ||
D89.2 | Hypergammaglobulinemia, unspecified | ||
I88.0 - I88.9 | Nonspecific lymphadenitis | ||
390 | Rheumatic fever without mention of heart involvement | I00 | Rheumatic fever without heart involvement |
391.0-391.9 | Rheumatic fever with heart involvement | I01.0 - I01.9 | Rheumatic fever with heart involvement |
392.0-392.9 | Rheumatic chorea | I02.0 - I02.9 | Rheumatic chorea |
393 | Chronic rheumatic pericarditis | I09.2 | Chronic rheumatic pericarditis |
394.0-394.9 | Diseases of mitral valve | I05.0 - I05.9 | Rheumatic mitral valve diseases |
395.0-395.9 | Diseases of aortic valve | I06.0 - I06.9 | Rheumatic aortic valve diseases |
396.0-396.9 | Diseases of mitral and aortic valves | I08.0 | Rheumatic disorders of both mitral and aortic valves |
I08.8 | Other rheumatic multiple valve diseases | ||
I08.9 | Rheumatic multiple valve disease, unspecified | ||
397.0-397.9 | Diseases of other endocardial structures | I07.0 - I07.9 | Rheumatic tricuspid valve diseases |
I08.1 | Rheumatic disorders of both mitral and tricuspid valves | ||
I08.2 | Rheumatic disorders of both aortic and tricuspid valves | ||
I08.3 | Combined rheumatic disorders of mitral, aortic and tricuspid valves | ||
I08.8 | Other rheumatic multiple valve diseases | ||
I08.9 | Rheumatic multiple valve disease, unspecified | ||
I09.1 | Rheumatic diseases of endocardium, valve unspecified | ||
I09.89 | Other specified rheumatic heart diseases | ||
398.0-398.99 | Other rheumatic heart disease | I09.0 | Rheumatic myocarditis |
I09.81 | Rheumatic heart failure | ||
I09.89 | Other specified rheumatic heart diseases | ||
I09.9 | Rheumatic heart disease, unspecified | ||
401-405.99 | Hypertension disease | I10 | Essential (primary) hypertension |
I11.0 - I11.9 | Hypertensive heart disease | ||
I12.0 - I12.9 | Hypertensive chronic kidney disease | ||
I13.0 - I13.2 | Hypertensive heart and chronic kidney disease | ||
I15.0 - I15.9 | Secondary hypertension | ||
I1A.0 | Resistant hypertension | ||
N26.2 | Page kidney | ||
403.00-403.90 | Hypertensive chronic kidney disease | I12.0 - I12.9 | Hypertensive chronic kidney disease |
404.00-404.93 | Hypertensive heart and chronic kidney disease | I13.0 - I13.2 | Hypertensive heart and chronic kidney disease |
I16.0, I16.1, I16.9 | Hypertensive crisis | ||
410.00-410.92 | Acute myocardial infarction | I21.01 - I21.4 | ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction |
I22.0 - I22.9 | Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction | ||
411.0-411.89 | Other acute and subacute forms of ischemic heart disease | I20.0 | Unstable angina |
I24.0 - I24.9 | Other acute ischemic heart diseases | ||
I25.110 | Atherosclerotic heart disease of native coronary artery with unstable angina pectoris | ||
I25.700 | Atherosclerosis of coronary artery bypass graft(s), unspecified, with unstable angina pectoris | ||
I25.710 | Atherosclerosis of autologous vein coronary artery bypass graft(s) with unstable angina pectoris | ||
I25.720 | Atherosclerosis of autologous artery coronary artery bypass graft(s) with unstable angina pectoris | ||
I25.730 | Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unstable angina pectoris | ||
I25.750 | Atherosclerosis of native coronary artery of transplanted heart with unstable angina | ||
I25.760 | Atherosclerosis of bypass graft of coronary artery of transplanted heart with unstable angina | ||
I25.790 | Atherosclerosis of other coronary artery bypass graft(s) with unstable angina pectoris | ||
412 | Old myocardial infarction | I25.2 | Old myocardial infarction |
413.0-413.9 | Angina pectoris | I20.1 | Angina pectoris with documented spasm |
I20.2 | Refractory angina pectoris | ||
I20.81 | Angina pectoris with coronary microvascular dysfunction | ||
I20.89 | Other forms of angina pectoris | ||
I20.9 | Angina pectoris, unspecified | ||
I25.111 | Atherosclerotic heart disease of native coronary artery with angina pectoris with documented spasm | ||
I25.112 | Atherosclerotic heart disease of native coronary artery with refractory angina pectoris | ||
I25.118 | Atherosclerotic heart disease of native coronary artery with other forms of angina pectoris | ||
I25.119 | Atherosclerotic heart disease of native coronary artery with unspecified angina pectoris | ||
I25.701 | Atherosclerosis of coronary artery bypass graft(s), unspecified, with angina pectoris with documented spasm | ||
I25.702 | Atherosclerosis of coronary artery bypass graft(s), unspecified, with refractory angina pectoris | ||
I25.708 | Atherosclerosis of coronary artery bypass graft(s), unspecified, with other forms of angina pectoris | ||
I25.709 | Atherosclerosis of coronary artery bypass graft(s), unspecified, with unspecified angina pectoris | ||
I25.711 | Atherosclerosis of autologous vein coronary artery bypass graft(s) with angina pectoris with documented spasm | ||
I25.712 | Atherosclerosis of autologous vein coronary artery bypass graft(s) with refractory angina pectoris | ||
I25.718 | Atherosclerosis of autologous vein coronary artery bypass graft(s) with other forms of angina pectoris | ||
I25.719 | Atherosclerosis of autologous vein coronary artery bypass graft(s) with unspecified angina pectoris | ||
I25.721 | Atherosclerosis of autologous artery coronary artery bypass graft(s) with angina pectoris with documented spasm | ||
I25.722 | Atherosclerosis of autologous artery coronary artery bypass graft(s) with refractory angina pectoris | ||
I25.728 | Atherosclerosis of autologous artery coronary artery bypass graft(s) with other forms of angina pectoris | ||
I25.729 | Atherosclerosis of autologous artery coronary artery bypass graft(s) with unspecified angina pectoris | ||
I25.731 | Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with angina pectoris with documented spasm | ||
I25.732 | Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with refractory angina pectoris | ||
I25.738 | Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with other forms of angina pectoris | ||
I25.739 | Atherosclerosis of nonautologous biological coronary artery bypass graft(s) with unspecified angina pectoris | ||
I25.751 | Atherosclerosis of native coronary artery of transplanted heart with angina pectoris with documented spasm | ||
I25.752 | Atherosclerosis of native coronary artery of transplanted heart with refractory angina pectoris | ||
I25.758 | Atherosclerosis of native coronary artery of transplanted heart with other forms of angina pectoris | ||
I25.759 | Atherosclerosis of native coronary artery of transplanted heart with unspecified angina pectoris | ||
I25.761 | Atherosclerosis of bypass graft of coronary artery of transplanted heart with angina pectoris with documented spasm | ||
I25.762 | Atherosclerosis of bypass graft of coronary artery of transplanted heart with refractory angina pectoris | ||
I25.768 | Atherosclerosis of bypass graft of coronary artery of transplanted heart with other forms of angina pectoris | ||
I25.769 | Atherosclerosis of bypass graft of coronary artery of transplanted heart with unspecified angina pectoris | ||
I25.791 | Atherosclerosis of other coronary artery bypass graft(s) with angina pectoris with documented spasm | ||
I25.792 | Atherosclerosis of other coronary artery bypass graft(s) with refractory angina pectoris | ||
I25.798 | Atherosclerosis of other coronary artery bypass graft(s) with other forms of angina pectoris | ||
I25.799 | Atherosclerosis of other coronary artery bypass graft(s) with unspecified angina pectoris | ||
414.00-414.9 | Other forms of chronic ischemic heart disease | I25.10 | Atherosclerotic heart disease of native coronary artery without angina pectoris |
I25.110 - I25.119 | Atherosclerotic heart disease of native coronary artery with angina pectoris | ||
I25.3 | Aneurysm of heart | ||
I25.41 - I25.42 | Coronary artery aneurysm and dissection | ||
I25.5 | Ischemic cardiomyopathy | ||
I25.6 | Silent myocardial ischemia | ||
I25.700 - I25.799 | Atherosclerosis of coronary artery bypass graft(s) and coronary artery of transplanted heart with angina pectoris | ||
I25.810 - I25.89 | Other forms of chronic ischemic heart disease | ||
I25.9 | Chronic ischemic heart disease, unspecified | ||
415.0-415.19 | Acute pulmonary heart disease | I26.01 - I26.99 | Pulmonary embolism |
T80.0XXA - T80.0XXS | Air embolism following infusion, transfusion and therapeutic injection | ||
T81.718A - T81.718S | Complication of other artery following a procedure, not elsewhere classified | ||
T81.72XA - T81.72XS | Complication of vein following a procedure, not elsewhere classified | ||
T82.817A - T82.817S | Embolism due to cardiac prosthetic devices, implants and grafts | ||
T82.818A - T82.818S | Embolism due to vascular prosthetic devices, implants and grafts | ||
416.0-416.9 | Chronic pulmonary heart disease | I27.0 - I27.9 | Other pulmonary heart diseases |
417.0-417.9 | Other diseases of pulmonary circulation | I28.0 - I28.9 | Other diseases of pulmonary vessels |
420.0-420.99 | Acute pericarditis | A18.84 | Tuberculosis of heart |
I30.0 - I30.9 | Acute pericarditis | ||
I32 | Pericarditis in diseases classified elsewhere | ||
M32.12 | Pericarditis in systemic lupus erythematosus | ||
421.0-421.9 | Acute and subacute endocarditis | I33.0 - I33.9 | Acute and subacute endocarditis |
I39 | Endocarditis and heart valve disorders in diseases classified elsewhere | ||
422.0-422.99 | Acute myocarditis | A18.84 | Tuberculosis of heart |
I40.0 - I40.9 | Acute myocarditis | ||
I41 | Myocarditis in diseases classified elsewhere | ||
423.0-423.9 | Other diseases of pericardium | I31.0 - I31.9 | Other diseases of pericardium |
424.0-424.99 | Other diseases of endocardium | A18.84 | Tuberculosis of heart |
I34.0 - I34.9 | Nonrheumatic mitral valve disorders | ||
I35.0 - I35.9 | Nonrheumatic aortic valve disorders | ||
I36.0 - I36.9 | Nonrheumatic tricuspid valve disorders | ||
I37.0 - I37.9 | Nonrheumatic pulmonary valve disorders | ||
I38 | Endocarditis, valve unspecified | ||
I39 | Endocarditis and heart valve disorders in diseases classified elsewhere | ||
M32.11 | Endocarditis in systemic lupus erythematosus | ||
425.0-425.9 | Cardiomyopathy | A18.84 | Tuberculosis of heart |
I42.0 - I42.9 | Cardiomyopathy | ||
I43 | Cardiomyopathy in diseases classified elsewhere | ||
426.0-426.9 | Conduction disorders | I44.0 - I44.7 | Atrioventricular and left bundle-branch block |
I45.0 - I45.9 | Other conduction disorders | ||
427.0-427.9 | Cardiac dysrhythmias | I46.2 | Cardiac arrest due to underlying cardiac condition |
I46.8 | Cardiac arrest due to other underlying condition | ||
I46.9 | Cardiac arrest, cause unspecified | ||
I47.0 - I47.9 | Paroxysmal tachycardia | ||
I48.0 - I48.92 | Atrial fibrillation and flutter | ||
I49.01 - I49.9 | Other cardiac arrhythmias | ||
R00.1 | Bradycardia, unspecified | ||
428.0-428.9 | Heart failure | I50.1 - I50.9 | Heart failure |
429.0-429.9 | Ill-defined descriptions and complications of heart disease | I23.0 - I23.9 | Certain current complications following ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction (within the 28 day period) |
I25.10 | Atherosclerotic heart disease of native coronary artery without angina pectoris | ||
I51.0 - I51.9 | Complications and ill-defined descriptions of heart disease | ||
I52 | Other heart disorders in diseases classified elsewhere | ||
I97.0 | Postcardiotomy syndrome | ||
I97.110 - I97.191 | Other postprocedural cardiac functional disturbances | ||
445.81 | Artheroembolism of kidney | I75.81 | Atheroembolism of kidney |
466.0-466.19 | Acute bronchitis and bronchiolitis | J20.0 - J20.9 | Acute bronchitis |
J21.0 - J21.9 | Acute bronchiolitis | ||
480.0-480.9 | Viral pneumonia | J12.0 - J12.9 | Viral pneumonia, not elsewhere classified |
J12.82 | Pneumonia due to coronavirus disease 2019 | ||
481 | Pneumococcal pneumonia [Streptococcus pneumoniae pneumonia] | J13 | Pneumonia due to Streptococcus pneumoniae |
J18.1 | Lobar pneumonia, unspecified organism | ||
482.0-482.9 | Other bacterial pneumonia | A48.1 | Legionnaires' disease |
J14 | Pneumonia due to Hemophilus influenzae | ||
J15.0 | Pneumonia due to Klebsiella pneumoniae | ||
J15.1 | Pneumonia due to Pseudomonas | ||
J15.20 - J15.29 | Pneumonia due to staphylococcus | ||
J15.3 | Pneumonia due to streptococcus, group B | ||
J15.4 | Pneumonia due to other streptococci | ||
J15.5 | Pneumonia due to Escherichia coli | ||
J15.61 | Pneumonia due to Acinetobacter baumannii | ||
J15.69 | Pneumonia due to other Gram-negative bacteria | ||
J15.7 | Pneumonia due to Mycoplasma pneumoniae | ||
J15.8 | Pneumonia due to other specified bacteria | ||
J15.9 | Unspecified bacterial pneumonia | ||
483.0-483.8 | Pneumonia due to other specified organism | J15.7 | Pneumonia due to Mycoplasma pneumoniae |
J16.0 | Chlamydial pneumonia | ||
J16.8 | Pneumonia due to other specified infectious organisms | ||
487.0-487.8 | Influenza | J10.00 - J10.89 | Influenza due to other identified influenza virus |
J11.00 - J11.89 | Influenza due to unidentified influenza virus | ||
488.01-488.89 | Influenza due to certain identified influenza viruses | J09.X1 - J09.X9 | Influenza due to certain identified influenza viruses |
J10.08 | Influenza due to other identified influenza virus with other specified pneumonia | ||
J10.1 | Influenza due to other identified influenza virus with other respiratory manifestations | ||
490 | Bronchitis, not specified as acute or chronic | J40 | Bronchitis, not specified as acute or chronic |
491.0-491.9 | Chronic bronchitis | J41.0 - J41.8 | Simple and mucopurulent chronic bronchitis |
J44.0 - J44.9 | Other chronic obstructive pulmonary disease | ||
492.0-492.8 | Emphysema | J43.0 - J43.9 | Emphysema |
493.00-493.92 | Asthma | J44.0 - J44.9 | Other chronic obstructive pulmonary disease |
J45.20 - J45.998 | Asthma | ||
494.0-494.1 | Bronchiectasis | J47.0 - J47.9 | Bronchiectasis |
495.0-495.9 | Extrinsic allergic alveolitis | J67.0 - J67.9 | Hypersensitivity pneumonitis due to organic dust |
496 | Chronic airway obstruction, not elsewhere classified | J44.9 | Chronic obstructive pulmonary disease, unspecified |
506.0-506.9 | Respiratory conditions due to chemical fumes and vapors | J68.0 - J68.9 | Respiratory conditions due to inhalation of chemicals, gases, fumes and vapors |
511.0-511.9 | Pleurisy | J86.9 | Pyothorax without fistula |
J90 | Pleural effusion, not elsewhere classified | ||
J91.0 - J91.8 | Pleural effusion in conditions classified elsewhere | ||
J92.0 - J92.9 | Pleural plaque | ||
J94.0 - J94.9 | Other pleural conditions | ||
R09.1 | Pleurisy | ||
516.0-516.9 | Other alveolar and parietoalveolar pneumonopathy | J84.01 - J84.09 | Alveolar and parieto-alveolar conditions |
J84.111 - J84.117 | Idiopathic interstitial pneumonia | ||
J84.2 | Lymphoid interstitial pneumonia | ||
J84.81 - J84.848 | Other specified interstitial pulmonary diseases | ||
J84.9 | Interstitial pulmonary disease, unspecified | ||
517.1-517.8 | Lung involvement in conditions classified elsewhere | D57.01 | Hb-SS disease with acute chest syndrome |
D57.211 | Sickle-cell/Hb-C disease with acute chest syndrome | ||
D57.411 | Sickle-cell thalassemia, unspecified, with acute chest syndrome | ||
D57.811 | Other sickle-cell disorders with acute chest syndrome | ||
J17 | Pneumonia in diseases classified elsewhere | ||
J99 | Respiratory disorders in diseases classified elsewhere | ||
M32.13 | Lung involvement in systemic lupus erythematosus | ||
M33.01 | Juvenile dermatopolymyositis with respiratory involvement | ||
M33.11 | Other dermatopolymyositis with respiratory involvement | ||
M33.21 | Polymyositis with respiratory involvement | ||
M33.91 | Dermatopolymyositis, unspecified with respiratory involvement | ||
M34.81 | Systemic sclerosis with lung involvement | ||
M35.02 | Sjogren syndrome with lung involvement | ||
518.0 - 518.89 | Other diseases of lung | B44.81 | Allergic bronchopulmonary aspergillosis |
J80 | Acute respiratory distress syndrome | ||
J81.0 | Acute pulmonary edema | ||
J82.81 | Chronic eosinophilic pneumonia | ||
J82.82 | Acute eosinophilic pneumonia | ||
J82.83 | Eosinophilic asthma | ||
J82.89 | Other pulmonary eosinophilia, not elsewhere classified | ||
J84.170 | Interstitial lung disease with progressive fibrotic phenotype in diseases classified elsewhere | ||
J84.178 | Other interstitial pulmonary diseases with fibrosis in diseases classified elsewhere | ||
J95.1 | Acute pulmonary insufficiency following thoracic surgery | ||
J95.2 | Acute pulmonary insufficiency following nonthoracic surgery | ||
J95.3 | Chronic pulmonary insufficiency following surgery | ||
J95.821 - J95.822 | Postprocedural respiratory failure | ||
J95.84 | Transfusion-related acute lung injury (TRALI) | ||
J96.00 - J96.92 | Respiratory failure, not elsewhere classified | ||
J98.11 - J98.19 | Pulmonary collapse | ||
J98.2 | Interstitial emphysema | ||
J98.3 | Compensatory emphysema | ||
J98.4 | Other disorders of lung | ||
519.2 | Mediastinitis | J98.51, J98.59 | Diseases of mediastinum, not elsewhere classified |
570 | Acute and subacute necrosis of liver | K72.00 - K72.01 | Acute and subacute hepatic failure |
K76.2 | Central hemorrhagic necrosis of liver | ||
571.0-571.9 | Chronic liver disease and cirrhosis | K70.0 - K70.9 | Alcoholic liver disease |
K73.0 - K73.9 | Chronic hepatitis, not elsewhere classified | ||
K74.00 - K74.69, K74.00, K74.01, K74.02 | Fibrosis and cirrhosis of liver | ||
K75.4 | Autoimmune hepatitis | ||
K75.81 | Nonalcoholic steatohepatitis (NASH) | ||
K76.0 | Fatty (change of) liver, not elsewhere classified | ||
K76.82 | Hepatic encephalopathy | ||
K76.89 | Other specified diseases of liver | ||
K76.9 | Liver disease, unspecified | ||
572.0-572.8 | Liver abscess and sequela of chronic liver disease | K70.41 | Alcoholic hepatic failure with coma |
K71.11 | Toxic liver disease with hepatic necrosis, with coma | ||
K72.01 | Acute and subacute hepatic failure with coma | ||
K72.10 - K72.11 | Chronic hepatic failure | ||
K72.90 - K72.91 | Hepatic failure, unspecified | ||
K75.0 | Abscess of liver | ||
K75.1 | Phlebitis of portal vein | ||
K76.6 | Portal hypertension | ||
K76.7 | Hepatorenal syndrome | ||
573.0-573.9 | Other disorders of liver | B25.1 | Cytomegaloviral hepatitis |
K71.0 - K71.9 | Toxic liver disease | ||
K75.2 | Nonspecific reactive hepatitis | ||
K75.3 | Granulomatous hepatitis, not elsewhere classified | ||
K75.81 - K75.89 | Other specified inflammatory liver diseases | ||
K75.9 | Inflammatory liver disease, unspecified | ||
K76.1 | Chronic passive congestion of liver | ||
K76.3 | Infarction of liver | ||
K76.4 | Peliosis hepatis | ||
K76.5 | Hepatic veno-occlusive disease | ||
K76.81 - K76.89 | Other specified diseases of liver | ||
K76.9 | Liver disease, unspecified | ||
K77 | Liver disorders in diseases classified elsewhere | ||
576.0-576.9 | Other disorders of biliary tract | K80.30 - K80.37 | Calculus of bile duct with cholangitis |
K83.01 - K83.9 | Other diseases of biliary tract | ||
K87 | Disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere | ||
K91.5 | Postcholecystectomy syndrome | ||
581.9 | Nephrotic syndrome with unspecified pathological lesion in kidney | N02.9 | Recurrent and persistent hematuria with unspecified morphologic changes |
N04.9 | Nephrotic syndrome with unspecified morphologic changes | ||
584.5-584.9 | Acute kidney failure | N17.0 - N17.9 | Acute kidney failure |
585.1-585.9 | Chronic kidney disease | N18.1 - N18.9, N18.30, N18.31, N18.32 | Chronic kidney disease (CKD) |
589.1 | Bilateral small kidneys | N27.1 | Small kidney, bilateral |
N13.0 | Hydronephrosis with ureteropelvic junction obstruction | ||
591 | Hydronephrosis | N13.1 | Hydronephrosis with ureteral stricture, not elsewhere classified |
N13.2 | Hydronephrosis with renal and ureteral calculous obstruction | ||
N13.30 - N13.39 | Other and unspecified hydronephrosis | ||
592.0-592.9 | Calculus of kidney | N20.0 - N20.9 | Calculus of kidney and ureter |
N22 | Calculus of urinary tract in diseases classified elsewhere | ||
593.0-593.9 | Other disorders of kidney and ureter | N11.1 | Chronic obstructive pyelonephritis |
N13.4 | Hydroureter | ||
N13.5 | Crossing vessel and stricture of ureter without hydronephrosis | ||
N13.70 - N13.9 | Vesicoureteral-reflux | ||
N28.0 | Ischemia and infarction of kidney | ||
N28.1 | Cyst of kidney, acquired | ||
N28.81 | Hypertrophy of kidney | ||
N28.82 | Megaloureter | ||
N28.83 | Nephroptosis | ||
N28.89 | Other specified disorders of kidney and ureter | ||
N28.9 | Disorder of kidney and ureter, unspecified | ||
N29 | Other disorders of kidney and ureter in diseases classified elsewhere | ||
R80.2 | Orthostatic proteinuria, unspecified | ||
617.0 | Endometriosis of uterus | N80.00 | Endometriosis of the uterus, unspecified |
N85.A | Isthmocele | ||
641.00-641.03 | Placenta previa without hemorrhage | O44.00 - O44.03 | Complete placenta previa NOS or without hemorrhage |
641.10-641.13 | Hemorrhage from placenta previa | O44.10 - O44.13 | Complete placenta previa with hemorrhage |
641.20-641.23 | Premature separation of placenta | O45.8X1 - O45.8X9 | Other premature separation of placenta |
O45.90 - O45.93 | Premature separation of placenta, unspecified | ||
641.30-641.33 | Antepartum hemorrhage associated with coagulation defects | O45.001 - O45.009 | Premature separation of placenta with coagulation defect, unspecified |
O45.011 - O45.019 | Premature separation of placenta with afibrinogenemia | ||
O45.021 - O45.029 | Premature separation of placenta with disseminated intravascular coagulation | ||
O45.091 - O45.099 | Premature separation of placenta with other coagulation defect | ||
641.81 | Other antepartum hemorrhage, with delivery | O46.8X1 | Other antepartum hemorrhage, first trimester |
O46.8X2 | Other antepartum hemorrhage, second trimester | ||
O46.8X3 | Other antepartum hemorrhage, third trimester | ||
O67.8 | Other intrapartum hemorrhage | ||
641.91 | Unspecified antepartum hemorrhage, with delivery | O46.91 | Antepartum hemorrhage, unspecified, first trimester |
O46.92 | Antepartum hemorrhage, unspecified, second trimester | ||
O46.93 | Antepartum hemorrhage, unspecified, third trimester | ||
O67.9 | Intrapartum hemorrhage, unspecified | ||
642.00-642.04 | Benign essential hypertension complicating pregnancy, childbirth, and the puerperium | O10.011 - O10.019 | Pre-existing essential hypertension complicating pregnancy, |
O10.02 | Pre-existing essential hypertension complicating childbirth | ||
O10.03 | Pre-existing essential hypertension complicating the puerperium | ||
O10.911 - O10.919 | Unspecified pre-existing hypertension complicating pregnancy | ||
O10.92 | Unspecified pre-existing hypertension complicating childbirth | ||
O10.93 | Unspecified pre-existing hypertension complicating the puerperium | ||
642.10-642.14 | Hypertension secondary to renal disease, complicating pregnancy, childbirth, and the puerperium | O10.411 - O10.419 | Pre-existing secondary hypertension complicating pregnancy |
O10.42 | Pre-existing secondary hypertension complicating childbirth | ||
O10.43 | Pre-existing secondary hypertension complicating the puerperium | ||
642.20-642.24 | Other pre-existing hypertension complicating pregnancy, childbirth, and the puerperium | O10.111 - O10.13 | Pre-existing hypertensive heart disease complicating pregnancy, childbirth and the puerperium |
O10.211 - O10.23 | Pre-existing hypertensive chronic kidney disease complicating pregnancy, childbirth and the puerperium | ||
O10.311 - O10.33 | Pre-existing hypertensive heart and chronic kidney disease complicating pregnancy, childbirth and the puerperium | ||
O11.1 - O11.9 | Pre-existing hypertension with pre-eclampsia | ||
642.30-642.34 | Transient hypertension of pregnancy | O13.1 - O13.9 | Gestational [pregnancy-induced] hypertension without significant proteinuria |
O16.1 | Unspecified maternal hypertension, first trimester | ||
O16.2 | Unspecified maternal hypertension, second trimester | ||
O16.3 | Unspecified maternal hypertension, third trimester | ||
642.40-642.44 | Mild or unspecified pre-eclampsia | O14.00 - O14.03 | Mild to moderate pre-eclampsia |
O14.90 - O14.93 | Unspecified pre-eclampsia | ||
O15.2 | Eclampsia in the puerperium | ||
642.50-642.54 | Severe pre-eclampsia | O14.10 - O14.13 | Severe pre-eclampsia |
O14.20 - O14.23 | HELLP syndrome | ||
642.60-642.64 | Eclampsia complicating pregnancy, childbirth or the puerperium | O15.00 - O15.09 | Eclampsia |
642.70-642.74 | Pre-eclampsia or eclampsia superimposed on pre-existing hypertension | O11.1 - O11.9 | Pre-existing hypertension with pre-eclampsia |
O15.2 | Eclampsia in the puerperium | ||
642.90-642.94 | Unspecified hypertension complicating pregnancy, childbirth, or the puerperium | O16.1 - O16.9 | Unspecified maternal hypertension |
644.20 | Early onset of delivery, unspecified as to episode of care | O60.10X0 - O60.10X9 | Preterm labor with preterm delivery, unspecified trimester |
O60.20X0 - O60.20X9 | Term delivery with preterm labor, unspecified trimester | ||
644.21 | Early onset of delivery, delivered, with or without mention of antepartum condition | O60.12X0 - O60.12X9 | Preterm labor second trimester with preterm delivery second trimester |
O60.13X0 - O60.13X9 | Preterm labor second trimester with preterm delivery third trimester | ||
O60.14X0 - O60.14X9 | Preterm labor third trimester with preterm delivery third trimester | ||
O60.22X0 - O60.22X9 | Term delivery with preterm labor, second trimester | ||
O60.23X0 - O60.23X9 | Term delivery with preterm labor, third trimester | ||
646.20-646.24 | Unspecified renal disease in pregnancy, without mention of hypertension | O12.10 - O12.13 | Gestational proteinuria |
O12.20 - O12.23 | Gestational edema with proteinuria | ||
O26.831 - O26.839 | Pregnancy related renal disease | ||
O90.89 | Other complications of the puerperium, not elsewhere classified | ||
646.70-646.73 | Liver and biliary tract disorders in pregnancy | O26.611 - O26.619 | Liver and biliary tract disorders in pregnancy |
O26.62 | Liver and biliary tract disorders in childbirth | ||
O26.643 | Intrahepatic cholestasis of pregnancy, third trimester | ||
O26.649 | Intrahepatic cholestasis of pregnancy, unspecified trimester | ||
647.00-647.04 | Maternal syphilis complicating pregnancy, childbirth, or the puerperium | O98.111 - O98.13 | Syphilis complicating pregnancy, childbirth and the puerperium |
647.30-647.34 | Maternal tuberculosis complicating pregnancy, childbirth, or the puerperium | O98.011 - O98.03 | Tuberculosis complicating pregnancy, childbirth and the puerperium |
647.40-647.44 | Maternal malaria complicating pregnancy, childbirth, or the puerperium | O98.611 - O98.63 | Protozoal diseases complicating pregnancy, childbirth and the puerperium |
647.50-647.54 | Maternal rubella complicating pregnancy, childbirth, or the puerperium | O98.511 - O98.53 | Other viral diseases complicating pregnancy, childbirth and the puerperium |
647.60-647.64 | Other maternal viral disease complicating pregnancy, childbirth, or the puerperium | O98.411 - O98.43 | Viral hepatitis complicating pregnancy, childbirth and the puerperium |
O98.511 - O98.53 | Other viral diseases complicating pregnancy, childbirth and the puerperium | ||
O98.711 - O98.73 | Human immunodeficiency virus [HIV] disease complicating pregnancy, childbirth and the puerperium | ||
647.80-647.84 | Other specified maternal infectious and parasitic disease complicating pregnancy, childbirth, or the puerperium | O98.611 | Protozoal diseases complicating pregnancy, first trimester |
O98.612 | Protozoal diseases complicating pregnancy, second trimester | ||
O98.613 | Protozoal diseases complicating pregnancy, third trimester | ||
O98.811 - O98.83 | Other maternal infectious and parasitic diseases complicating pregnancy, childbirth and the puerperium | ||
O99.830 - O98.835 | Other infection carrier state complicating pregnancy, childbirth and the puerperium | ||
647.90-647.94 | Unspecified maternal infection or infestation complicating pregnancy, childbirth, or the puerperium | O98.911 - O98.93 | Unspecified maternal infectious and parasitic disease complicating pregnancy, childbirth and the puerperium |
648.00-648.04 | Maternal diabetes mellitus complicating pregnancy, childbirth, or the puerperium | O24.011 - O24.03 | Pre-existing diabetes mellitus, type 1, in pregnancy, childbirth and the puerperium |
O24.111 - O24.13 | Pre-existing diabetes mellitus, type 2, in pregnancy, childbirth and the puerperium | ||
O24.311 - O24.33 | Unspecified pre-existing diabetes mellitus in pregnancy, childbirth and the puerperium | ||
O24.811 - O24.83 | Other pre-existing diabetes mellitus in pregnancy, childbirth, and the puerperium | ||
O24.911 - O24.93 | Unspecified diabetes mellitus in pregnancy, childbirth and the puerperium | ||
648.50-648.54 | Maternal congenital cardiovascular disorders | O99.411 - O99.43 | Diseases of the circulatory system complicating pregnancy |
648.60-648.64 | Other maternal cardiovascular diseases | O99.411 - O99.43 | Diseases of the circulatory system complicating pregnancy |
648.80-648.84 | Abnormal glucose tolerance | O24.410 - O24.439 | Gestational diabetes mellitus |
O99.810 - O99.815 | Abnormal glucose complicating pregnancy, childbirth and the puerperium | ||
649.30-649.34 | Coagulation defects complicating pregnancy, childbirth, or the puerperium | O99.111 - O99.13 | Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy |
649.40-649.44 | Epilepsy complicating pregnancy, childbirth, or the puerperium | O99.350 - O99.355 | Diseases of the nervous system complicating pregnancy, childbirth, and the puerperium |
651.00-651.93 | Multiple gestation | O30.001 - O30.009 | Twin pregnancy, unspecified number of placenta and unspecified number of amniotic sacs |
O30.011 - O30.019 | Twin pregnancy, monochorionic/monoamniotic | ||
O30.031 - O30.039 | Twin pregnancy, monochorionic/diamniotic | ||
O30.041 - O30.049 | Twin pregnancy, dichorionic/diamniotic | ||
O30.091 - O30.099 | Twin pregnancy, unable to determine number of placenta and number of amniotic sacs | ||
O30.101 - O30.199 | Triplet pregnancy | ||
O30.201 - O30.299 | Quadruplet pregnancy | ||
O30.801 - O30.899 | Other specified multiple gestation | ||
O30.90 - O30.93 | Multiple gestation, unspecified | ||
O31.10X0 - O31.139X | Continuing pregnancy after spontaneous abortion of one fetus or more | ||
O31.20X0 - O31.23X9 | Continuing pregnancy after intrauterine death of one fetus or more | ||
O31.30X0 - O31.33X9 | Continuing pregnancy after elective fetal reduction of one fetus or more | ||
O31.8X10 - O31.8X99 | Other complications specific to multiple gestation | ||
651.30-651.33 | Twin pregnancy with fetal loss and retention of one fetus | O31.10X0 | Continuing pregnancy after spontaneous abortion of one fetus or more, unspecified trimester, not applicable or unspecified |
O31.10X1 | Continuing pregnancy after spontaneous abortion of one fetus or more, unspecified trimester, fetus 1 | ||
O31.10X2 | Continuing pregnancy after spontaneous abortion of one fetus or more, unspecified trimester, fetus 2 | ||
O31.11X0 | Continuing pregnancy after spontaneous abortion of one fetus or more, first trimester, not applicable or unspecified | ||
O31.11X1 | Continuing pregnancy after spontaneous abortion of one fetus or more, first trimester, fetus 1 | ||
O31.11X2 | Continuing pregnancy after spontaneous abortion of one fetus or more, first trimester, fetus 2 | ||
O31.12X0 | Continuing pregnancy after spontaneous abortion of one fetus or more, second trimester, not applicable or unspecified | ||
O31.12X1 | Continuing pregnancy after spontaneous abortion of one fetus or more, second trimester, fetus 1 | ||
O31.12X2 | Continuing pregnancy after spontaneous abortion of one fetus or more, second trimester, fetus 2 | ||
O31.13X0 | Continuing pregnancy after spontaneous abortion of one fetus or more, third trimester, not applicable or unspecified | ||
O31.13X1 | Continuing pregnancy after spontaneous abortion of one fetus or more, third trimester, fetus 1 | ||
O31.13X2 | Continuing pregnancy after spontaneous abortion of one fetus or more, third trimester, fetus 2 | ||
O31.20X0 | Continuing pregnancy after intrauterine death of one fetus or more, unspecified trimester, not applicable or unspecified | ||
O31.20X1 | Continuing pregnancy after intrauterine death of one fetus or more, unspecified trimester, fetus 1 | ||
O31.20X2 | Continuing pregnancy after intrauterine death of one fetus or more, unspecified trimester, fetus 2 | ||
O31.21X0 | Continuing pregnancy after intrauterine death of one fetus or more, first trimester, not applicable or unspecified | ||
O31.21X1 | Continuing pregnancy after intrauterine death of one fetus or more, first trimester, fetus 1 | ||
O31.21X2 | Continuing pregnancy after intrauterine death of one fetus or more, first trimester, fetus 2 | ||
O31.22X0 | Continuing pregnancy after intrauterine death of one fetus or more, second trimester, not applicable or unspecified | ||
O31.22X1 | Continuing pregnancy after intrauterine death of one fetus or more, second trimester, fetus 1 | ||
O31.22X2 | Continuing pregnancy after intrauterine death of one fetus or more, second trimester, fetus 2 | ||
O31.23X0 | Continuing pregnancy after intrauterine death of one fetus or more, third trimester, not applicable or unspecified | ||
O31.23X1 | Continuing pregnancy after intrauterine death of one fetus or more, third trimester, fetus 1 | ||
O31.23X2 | Continuing pregnancy after intrauterine death of one fetus or more, third trimester, fetus 2 | ||
651.40-651.43 | Triplet pregnancy with fetal loss and retention of one or more fetus(es) | O31.10X0 | Continuing pregnancy after spontaneous abortion of one fetus or more, unspecified trimester, not applicable or unspecified |
O31.11X0 | Continuing pregnancy after spontaneous abortion of one fetus or more, first trimester, not applicable or unspecified | ||
651.50-651.53 | Quadruplet pregnancy with fetal loss and retention of one or more fetus(es) | O31.10X0 | Continuing pregnancy after spontaneous abortion of one fetus or more, unspecified trimester, not applicable or unspecified |
O31.11X0 | Continuing pregnancy after spontaneous abortion of one fetus or more, first trimester, not applicable or unspecified | ||
651.60-651.63 | Other multiple pregnancy with fetal loss and retention of one or more fetus(es) | O31.10X0 - O31.13X9 | Continuing pregnancy after spontaneous abortion of one fetus or more |
O31.20X0 - O31.23X9 | Continuing pregnancy after intrauterine death of one fetus or more | ||
652.00-652.03 | Unstable lie of fetus | O32.0XX0 - O32.0XX9 | Maternal care for unstable lie |
652.60-652.63 | Multiple gestation with malpresentation of one fetus or more | O32.9XX0 - O32.9XX9 | Maternal care for malpresentation of fetus, unspecified |
O66.6 | Obstructed labor due to other multiple fetuses | ||
652.70-652.73 | Prolapsed arm of fetus | O32.8XX0 | Maternal care for other malpresentation of fetus, not applicable or unspecified |
653.60-653.63 | Hydrocephalic fetus causing disproportion | O33.6XX0 - O33.6XX9 | Maternal care for disproportion due to hydrocephalic fetus |
O34.212 | Maternal care for vertical scar from previous cesarean delivery | ||
O34.218 | Maternal care for other type scar from previous cesarean delivery | ||
O34.22 | Maternal care for cesarean scar defect (isthmocele) | ||
O44.20 - O44.23, O44.30 - O44.33, O44.40 - O44.43, O44.50 - O44.53 | Placenta previa | ||
654.90-654.94 | Other and unspecified abnormality of organs and soft tissues of pelvis complicating pregnancy, childbirth, and the puerperium | O34.29 | Maternal care due to uterine scar from other previous surgery |
O34.80 - O34.83 | Maternal care for other abnormalities of pelvic organs | ||
O34.90 - O34.93 | Maternal care for abnormality of pelvic organ, unspecified | ||
O65.8 | Obstructed labor due to other maternal pelvic abnormalities | ||
O65.9 | Obstructed labor due to maternal pelvic abnormality, unspecified | ||
655.00-655.93 | Known or suspected fetal abnormality affecting management of mother | O35.00X0, O35.00X1, O35.00X2, O35.00X3, O35.00X4, O35.00X5, O35.00X9 | Maternal care for (suspected) central nervous system malformation or damage in fetus |
O35.01X0, O35.01X1, O35.01X2, O35.01X3, O35.01X4, O35.01X5, O35.01X9 | Maternal care for (suspected) central nervous system malformation or damage in fetus, agenesis of the corpus callosum | ||
O35.02X0, O35.02X1, O35.02X2, O35.02X3, O35.02X4, O35.02X5, O35.02X9 | Maternal care for (suspected) central nervous system malformation or damage in fetus, anencephaly | ||
O35.03X0, O35.03X1, O35.03X2, O35.03X3, O35.03X4, O35.03X5, O35.03X9 | Maternal care for (suspected) central nervous system malformation or damage in fetus, choroid plexus cysts | ||
O35.04X0, O35.04X1, O35.04X2, O35.04X3, O35.04X4, O35.04X5, O35.04X9 | Maternal care for (suspected) central nervous system malformation or damage in fetus, encephalocele | ||
O35.05X0, O35.05X1, O35.05X2, O35.05X3, O35.05X4, O35.05X5, O35.05X9 | Maternal care for (suspected) central nervous system malformation or damage in fetus, holoprosencephaly | ||
O35.06X0, O35.06X1, O35.06X2, O35.06X3, O35.06X4, O35.06X5, O35.06X9 | Maternal care for (suspected) central nervous system malformation or damage in fetus, hydrocephaly | ||
O35.07X0, O35.07X1, O35.07X2, O35.07X3, O35.07X4, O35.07X5, O35.07X9 | Maternal care for (suspected) central nervous system malformation or damage in fetus, microcephaly | ||
O35.08X0, O35.08X1, O35.08X2, O35.08X3, O35.08X4, O35.08X5, O35.08X9 | Maternal care for (suspected) central nervous system malformation or damage in fetus, spina bifida | ||
O35.09X0, O35.09X1, O35.09X2, O35.09X3, O35.09X4, O35.09X5, O35.09X9 | Maternal care for (suspected) other central nervous system malformation or damage in fetus | ||
O35.10X0, O35.10X1, O35.10X2, O35.10X3, O35.10X4, O35.10X5, O35.10X9 | Maternal care for (suspected) chromosomal abnormality in fetus, unspecified | ||
O35.11X0, O35.11X1, O35.11X2, O35.11X3, O35.11X4, O35.11X5, O35.11X9 | Maternal care for (suspected) chromosomal abnormality in fetus, Trisomy 13 | ||
O35.12X0, O35.12X1, O35.12X2, O35.12X3, O35.12X4, O35.12X5, O35.12X9 | Maternal care for (suspected) chromosomal abnormality in fetus, Trisomy 18 | ||
O35.13X0, O35.13X1, O35.13X2, O35.13X3, O35.13X4, O35.13X5, O35.13X9 | Maternal care for (suspected) chromosomal abnormality in fetus, Trisomy 21 | ||
O35.14X0, O35.14X1, O35.14X2, O35.14X3, O35.14X4, O35.14X5, O35.14X9 | Maternal care for (suspected) chromosomal abnormality in fetus, Turner Syndrome | ||
O35.15X0, O35.15X1, O35.15X2, O35.15X3, O35.15X4, O35.15X5, O35.15X9 | Maternal care for (suspected) chromosomal abnormality in fetus, sex chromosome abnormality | ||
O35.19X0, O35.19X1, O35.19X2, O35.19X3, O35.19X4, O35.19X5, O35.19X9 | Maternal care for (suspected) chromosomal abnormality in fetus, other chromosomal abnormality | ||
O35.2XX0 - O35.2XX9 | Maternal care for (suspected) hereditary disease in fetus | ||
O35.3XX0 - O35.3XX9 | Maternal care for (suspected) damage to fetus from viral disease in mother | ||
O35.4XX0 - O35.4XX9 | Maternal care for (suspected) damage to fetus from alcohol | ||
O35.5XX0 - O35.5XX9 | Maternal care for (suspected) damage to fetus by drugs | ||
O35.6XX0 - O35.6XX9 | Maternal care for (suspected) damage to fetus by radiation | ||
O35.AXX0, O35.AXX1, O35.AXX2, O35.AXX3, O35.AXX4, O35.AXX5, O35.AXX9 | Maternal care for other (suspected) fetal abnormality and damage, fetal facial anomalies | ||
O35.BXX0, O35.BXX1, O35.BXX2, O35.BXX3, O35.BXX4, O35.BXX5, O35.BXX9 | Maternal care for other (suspected) fetal abnormality and damage, fetal cardiac anomalies | ||
O35.CXX0, O35.CXX1, O35.CXX2, O35.CXX3, O35.CXX4, O35.CXX5, O35.CXX9 | Maternal care for other (suspected) fetal abnormality and damage, fetal pulmonary anomalies | ||
O35.DXX0, O35.DXX1, O35.DXX2, O35.DXX3, O35.DXX4, O35.DXX5, O35.DXX9 | Maternal care for other (suspected) fetal abnormality and damage, fetal gastrointestinal anomalies | ||
O35.EXX0, O35.EXX1, O35.EXX2, O35.EXX3, O35.EXX4, O35.EXX5, O35.EXX9 | Maternal care for other (suspected) fetal abnormality and damage, fetal genitourinary anomalies | ||
O35.FXX0, O35.FXX1, O35.FXX2, O35.FXX3, O35.FXX4, O35.FXX5, O35.FXX9 | Maternal care for other (suspected) fetal abnormality and damage, fetal musculoskeletal anomalies of trunk | ||
O35.GXX0, O35.GXX1, O35.GXX2, O35.GXX3, O35.GXX4, O35.GXX5, O35.GXX9 | Maternal care for other (suspected) fetal abnormality and damage, fetal upper extremities anomalies | ||
O35.HXX0, O35.HXX1, O35.HXX2, O35.HXX3, O35.HXX4, O35.HXX5, O35.HXX9 | Maternal care for other (suspected) fetal abnormality and damage, fetal lower extremities anomalies | ||
O35.8XX0 - O35.8XX9 | Maternal care for other (suspected) fetal abnormality and damage | ||
O35.9XX0 - O35.9XX9 | Maternal care for (suspected) fetal abnormality and damage, unspecified | ||
O36.8120 - O36.8129 | Decreased fetal movements, second trimester | ||
O36.8130 - O36.8139 | Decreased fetal movements, third trimester | ||
O36.8190 - O36.8199 | Decreased fetal movements, unspecified trimester | ||
656.00-656.03 | Fetal-maternal hemorrhage affecting management of mother | O43.011 - O43.019 | Fetomaternal placental transfusion syndrome |
656.10-656.13 | Rhesus isoimmunization affecting management of mother | O36.0110 - O36.0999 | Maternal care for rhesus isoimmunization |
656.20-656.23 | Isoimmunization from other and unspecified blood-group incompatibility affecting management of mother | O36.1110 - O36.1999 | Maternal care for other isoimmunization |
656.30-656.33 | Fetal distress affecting management of mother | O68 | Labor and delivery |
656.40-656.43 | Intrauterine death | O36.4XX0 - O36.4XX9 | Maternal care for intrauterine death |
656.50-656.53 | Poor fetal growth affecting management of mother | O36.5110 - O36.5999 | Maternal care for known or suspected poor fetal growth |
656.70-656.73 | Other placental conditions affecting management of mother | O43.021 - O43.029 | Fetus-to-fetus placental transfusion syndrome |
O43.101 - O43.109 | Malformation of placenta | ||
O43.111 - O43.119 | Circumvallate placenta | ||
O43.191 - O43.199 | Other malformation of placenta | ||
O43.811 - O43.819 | Placental infarction | ||
O43.90 - O43.93 | Unspecified placental disorder | ||
657.00-657.03 | Polyhydramnios | O40.1XX0 - O40.9XX9 | Polyhydramnios |
658.00-658.03 | Oligohydramnios | O41.00X0 - O41.03X9 | Oligohydramnios |
658.10-658.13 | Premature rupture of membranes | O42.00 - O42.02 | Premature rupture of membranes, onset of labor within 24 hours of rupture |
O42.90 - O42.92 | Premature rupture of membranes, unspecified as to length of time between rupture and onset of labor | ||
658.20-658.23 | Delayed delivery after spontaneous or unspecified rupture of membranes | O42.10 - O42.12 | Premature rupture of membranes, onset of labor more than 24 hours following rupture |
658.40-658.43 | Infection of amniotic cavity | O41.1010 - O41.1499 | Infection of amniotic sac and membranes |
659.70-659.73 | Abnormality in fetal heart rate or rhythm | O76 | Abnormality in fetal heart rate and rhythm complicating labor and delivery |
663.01 | Prolapse of cord, complicating labor and delivery, delivered | O69.0XX0 - O69.0XX9 | Labor and delivery complicated by prolapse of cord |
663.51 | Vasa previa complicating labor and delivery, delivered | O69.4XX0 - O69.4XX9 | Labor and delivery complicated by vasa previa |
665.01 | Rupture of uterus before onset of labor, with delivery | O71.02 | Rupture of uterus before onset of labor, second trimester |
O71.03 | Rupture of uterus before onset of labor, third trimester | ||
673.00-673.84 | Obstetrical pulmonary embolism | O88.011 - O88.83 | Obstetric embolism |
674.51-674.54 | Peripartum cardiomyopathy, delivered, with or without mention of antepartum condition | O90.3 | Peripartum cardiomyopathy |
745.0-745.9 | Bulbus cordis anomalies and anomalies of cardiac septal closure | Q20.0 | Common arterial trunk |
Q20.1 | Double outlet right ventricle | ||
Q20.2 | Double outlet left ventricle | ||
Q20.3 | Discordant ventriculoarterial connection | ||
Q20.4 | Double inlet ventricle | ||
Q20.5 | Discordant atrioventricular connection | ||
Q20.6 | Isomerism of atrial appendages | ||
Q20.8 | Other congenital malformations of cardiac chambers and connections | ||
Q21.0 - Q21.9 | Congenital malformations of cardiac septa | ||
746.0-746.9 | Other congenital anomalies of heart | Q20.9 | Congenital malformation of cardiac chambers and connections, unspecified |
Q22.0 - Q22.9 | Congenital malformations of pulmonary and tricuspid valves | ||
Q23.0 - Q23.9 | Congenital malformations of aortic and mitral valves | ||
Q24.0 - Q24.9 | Other congenital malformations of heart | ||
747.0-747.9 | Other congenital anomalies of circulatory system | P29.38 | Persistent fetal circulation |
Q25.0 - Q25.9 | Congenital malformations of great arteries | ||
Q26.0 - Q26.9 | Congenital malformations of great veins | ||
Q27.0 - Q27.9 | Other congenital malformations of peripheral vascular system | ||
Q28.0 - Q28.9 | Other congenital malformations of circulatory system | ||
751.60 | Unspecified anomaly of gallbladder, bile ducts, and liver | Q44.1 | Other congenital malformations of gallbladder |
Q44.5 | Other congenital malformations of bile ducts | ||
Q44.7 | Other congenital malformations of liver | ||
751.62 | Congenital cystic disease of liver | Q44.6 | Cystic disease of liver |
751.69 | Other anomalies of gallbladder, bile ducts, and liver | Q44.0 | Agenesis, aplasia and hypoplasia of gallbladder |
Q44.1 | Other congenital malformations of gallbladder | ||
Q44.4 | Choledochal cyst | ||
Q44.5 | Other congenital malformations of bile ducts | ||
Q44.7 | Other congenital malformations of liver (Deleted 09/30/2023) | ||
Q44.70 | Other congenital malformation of liver, unspecified (New 10/01/2023) | ||
Q44.71 | Alagille syndrome (New 10/01/2023) | ||
Q44.79 | Other congenital malformations of liver (New 10/01/2023) | ||
753.0-753.9 | Congenital anomalies of urinary system | Q60.0 - Q60.6 | Renal agenesis and other reduction defects of kidney |
Q61.00 - Q61.9 | Cystic kidney disease | ||
Q62.0 - Q62.8 | Congenital obstructive defects of renal pelvis and congenital malformations of ureter | ||
Q63.0 - Q63.9 | Other congenital malformations of kidney | ||
Q64.10 - Q64.19 | Exstrophy of urinary bladder | ||
Q64.2 | Congenital posterior urethral valves | ||
Q64.31 - Q64.39 | Other atresia and stenosis of urethra and bladder neck | ||
Q64.4 | Malformation of urachus | ||
Q64.5 | Congenital absence of bladder and urethra | ||
Q64.6 | Congenital diverticulum of bladder | ||
Q64.70 - Q64.79 | Other and unspecified congenital malformations of bladder and urethra | ||
Q64.8 | Other specified congenital malformations of urinary system | ||
Q64.9 | Congenital malformation of urinary system, unspecified | ||
761.6 | Fetus or newborn affected by maternal death | P01.6 | Newborn affected by maternal death |
764.90-764.99 | Fetal growth retardation, unspecified | P05.9 | Newborn affected by slow intrauterine growth, unspecified |
768.2 | Fetal distress before onset of labor, in liveborn infant | P19.0 | Metabolic acidemia in newborn first noted before onset of labor |
773.0 | Hemolytic disease due to Rh isoimmuni- zation | P55.0 | Rh isoimmunization of newborn |
773.1 | Hemolytic disease due to ABO isoimmumization | P55.1 | ABO isoimmunization of newborn |
773.2 | Hemolytic disease due to other and unspecified isoimmunization | P55.8 | Other hemolytic diseases of newborn |
P55.9 | Hemolytic disease of newborn, unspecified | ||
773.3 | Hydrops fetalis due to isoimmunization | P56.0 | Hydrops fetalis due to isoimmunization |
P56.90 | Hydrops fetalis due to unspecified hemolytic disease | ||
P56.99 | Hydrops fetalis due to other hemolytic disease | ||
P78.84 | Gestational alloimmune liver disease | ||
782.4 | Jaundice, unspecified, not of newborn | R17 | Unspecified jaundice |
789.51 | Malignant ascites | R18.0 | Malignant ascites |
789.59 | Other ascites | R18.8 | Other ascites |
790.92 | Abnormal coagulation profile | R79.1 | Abnormal coagulation profile |
866.00 - 866.13 | Injury to kidney | S31.001A - S31.001S | Unspecified open wound of lower back and pelvis with penetration into retroperitoneum |
S37.001A - S37.099S | Injury of kidney | ||
V08 | Asymptomatic human immunodeficiency virus [HIV] infection status | Z21 | Asymptomatic human immunodeficiency virus [HIV] infection status |
V10.52 | Personal history of malignant neoplasm of kidney | Z85.528 | Personal history of other malignant neoplasm of kidney |
V12.21 | Personal history of gestational diabetes | Z86.32 | Personal history of gestational diabetes |
V16.51 | Family history of malignant neoplasm of kidney | Z80.51 | Family history of malignant neoplasm of kidney |
V23.49 | Supervision of pregnancy with other poor obstetric history | O09.291 - O09.299 | Supervision of pregnancy with other poor reproductive or obstetric history |
V23.5 | Pregnancy with other poor reproductive history | O09.291 - O09.299 | Supervision of pregnancy with other poor reproductive or obstetric history |
V23.85 | Supervision of high risk pregnancy, pregnancy resulting from assisted reproductive technology | O09.811 - O09.819 | Supervision of pregnancy resulting from assisted reproductive technology |
V23.89 | Supervision of other high-risk pregnancy | O09.70 - O09.73 | Supervision of high risk pregnancy due to social problems |
O09.891 - O09.899 | Supervision of other high risk pregnancies | ||
V27.1 | Single stillborn | Z37.1 | Single stillbirth |
V27.4 | Twins, both stillborn | Z37.4 | Twins, both stillborn |
V27.7 | Other multiple birth, all stillborn | Z37.7 | Other multiple births, all stillborn |
V58.67 | Long-term (current) use of insulin | Z79.4 | Long term (current) use of insulin |
V91.00-V91.99 | Multiple gestation placenta status | O30.001 - O30.009 | Twin pregnancy, unspecified number of placenta and unspecified number of amniotic sacs |
O30.011 - O30.019 | Twin pregnancy, monochorionic/monoamniotic | ||
O30.031 - O30.039 | Twin pregnancy, monochorionic/diamniotic | ||
O30.041 - O30.049 | Twin pregnancy, dichorionic/diamniotic | ||
O30.091 - O30.099 | Twin pregnancy, unable to determine number of placenta and number of amniotic sacs | ||
O30.101 - O30.199 | Triplet pregnancy | ||
O30.201 - O30.299 | Quadruplet pregnancy | ||
O30.801 - O30.899 | Other specified multiple gestation |
CPT copyright American Medical Association. All rights reserved. CPT is a registered trademark of the American Medical Association.